AMRX: 3 Growth Drivers Behind Amneal's 2026 Outlook
Amneal Pharmaceuticals heads into 2026 with diversified growth drivers, rising margins and a faster launch cadence supporting steady revenue expansion.
Zacks·1d ago
More News
Is AMRX Stock Undervalued? Sales Multiple, Target, Upside
Amneal Pharmaceuticals trades below peers on sales multiple despite strong gains, with a $14 target hinging on execution, mix shift, and margin strength.
Zacks·1d ago
Here's How AMRX Is Tapping GLP-1 Demand Through Manufacturing
Amneal Pharmaceuticals taps GLP-1 growth via a Pfizer-linked manufacturing deal, gaining exposure without clinical risks while scaling injectables and peptides.
Zacks·1d ago
Teva Pharmaceutical Industries (NYSE:TEVA) Given New $42.00 Price Target at Bank of America
Bank of America raised their target price on shares of Teva Pharmaceutical Industries from $38.00 to $42.00 and gave the stock a "buy" rating in a research note on Thursday...
MarketBeat·2d ago
Should You Buy, Sell or Hold JNJ Stock Ahead of Q1 Earnings?
JNJ approaches Q1 results with strong drug growth and MedTech momentum. However, rising biosimilar competition and pricing pressures cloud the outlook.
Zacks·2d ago
MH & Associates Securities Management Corp ADV Invests $4.33 Million in Teva Pharmaceutical Industries Ltd. $TEVA
MH & Associates Securities Management Corp ADV acquired a new position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 138,731 shares of the company's...
MarketBeat·2d ago
Teva Pharmaceutical Industries Ltd. $TEVA Shares Sold by Aberdeen Group plc
Aberdeen Group plc decreased its stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 79.7% during the 4th quarter, according to the company in its most recent disclosure with...
MarketBeat·3d ago
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Receives Consensus Rating of "Moderate Buy" from Analysts
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Get Free Report) has been given an average recommendation of "Moderate Buy" by the eleven brokerages that are currently covering the firm, Marketbeat...
MarketBeat·3d ago
Sowell Financial Services LLC Grows Position in Teva Pharmaceutical Industries Ltd. $TEVA
Sowell Financial Services LLC lifted its holdings in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 107.6% in the fourth quarter, according to the company in its most...
MarketBeat·4d ago
Teva Pharmaceutical Industries (NYSE:TEVA) Shares Gap Down - Here's What Happened
Teva Pharmaceutical Industries (NYSE:TEVA) Shares Gap Down - Here's Why...